Form 4 for BHC Bausch Health Companies Inc.

Accepted 2022-03-04 00:00:00 ET · period of report 2022-03-02 · accession 0001127602-22-008251 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-03-04	2022-03-02	BHC	Spurr Robert	U.S. Pres-Pharma Business	A - Grant	$24.17	+35.6K	101.0K	+54%	+$861.1K
D	2022-03-04	2022-03-02	BHC	Spurr Robert	U.S. Pres-Pharma Business	S - Sale	$23.37	-1,595	65.4K	-2%	-$37.3K
D	2022-03-04	2022-03-02	BHC	Spurr Robert	U.S. Pres-Pharma Business	A - Grant	$0.00	+131.9K	131.9K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Shares, No Par Value	2022-03-02	A	A	35,627	$24.17	101,021	D	—	—	(F2) Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
2	Common	Common Shares, No Par Value	2022-03-02	S	D	1,595	$23.37	65,394	D	—	—	(F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.
3	Derivative	Non-Qualified Stock Options (right to purchase)	2022-03-02	A	A	131,910	$0.00	131,910	D	$24.17 · — to 2032-03-02	131,910 Common Shares, No Par Value	(F3) The options vest in equal installments on each of the first three anniversaries of the date of grant.